

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.05674966 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.05674966 |
| 3 | piRNA metabolic process (GO:0034587) | 5.99463551 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.75151425 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.75151425 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.25302868 |
| 7 | cysteine metabolic process (GO:0006534) | 5.17275739 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.04041701 |
| 9 | bile acid biosynthetic process (GO:0006699) | 5.03191926 |
| 10 | urate metabolic process (GO:0046415) | 4.92531655 |
| 11 | urea metabolic process (GO:0019627) | 4.82940266 |
| 12 | urea cycle (GO:0000050) | 4.82940266 |
| 13 | response to peptidoglycan (GO:0032494) | 4.79837176 |
| 14 | phospholipid homeostasis (GO:0055091) | 4.64601435 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.63760591 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 4.63129377 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 4.63129377 |
| 18 | tryptophan catabolic process (GO:0006569) | 4.63129377 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.62404484 |
| 20 | lysine metabolic process (GO:0006553) | 4.60972573 |
| 21 | lysine catabolic process (GO:0006554) | 4.60972573 |
| 22 | glyoxylate metabolic process (GO:0046487) | 4.58465875 |
| 23 | regulation of female gonad development (GO:2000194) | 4.58139339 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.58050102 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 4.58050102 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 4.58050102 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 4.58050102 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.58050102 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.58050102 |
| 30 | tryptophan metabolic process (GO:0006568) | 4.53585092 |
| 31 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.41212483 |
| 32 | neutrophil activation involved in immune response (GO:0002283) | 4.39518355 |
| 33 | * DNA methylation involved in gamete generation (GO:0043046) | 4.38430918 |
| 34 | sulfur amino acid catabolic process (GO:0000098) | 4.35189739 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 4.34072800 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.29832916 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 4.29463383 |
| 38 | bile acid metabolic process (GO:0008206) | 4.15100126 |
| 39 | positive regulation of humoral immune response (GO:0002922) | 4.14491805 |
| 40 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.11667855 |
| 41 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.11104645 |
| 42 | detection of other organism (GO:0098543) | 4.10759239 |
| 43 | negative regulation of fibrinolysis (GO:0051918) | 4.05887089 |
| 44 | cellular extravasation (GO:0045123) | 4.03562089 |
| 45 | high-density lipoprotein particle remodeling (GO:0034375) | 4.03222755 |
| 46 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.00147319 |
| 47 | protein carboxylation (GO:0018214) | 4.00147319 |
| 48 | homocysteine metabolic process (GO:0050667) | 3.97702273 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 3.96776247 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 3.94615062 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 3.89458140 |
| 52 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.86891946 |
| 53 | glycine metabolic process (GO:0006544) | 3.85707946 |
| 54 | regulation of acrosome reaction (GO:0060046) | 3.83408741 |
| 55 | complement activation, alternative pathway (GO:0006957) | 3.83279294 |
| 56 | regulation of protein activation cascade (GO:2000257) | 3.79351691 |
| 57 | serine family amino acid metabolic process (GO:0009069) | 3.75237505 |
| 58 | detection of bacterium (GO:0016045) | 3.73520913 |
| 59 | regulation of gamma-delta T cell activation (GO:0046643) | 3.73464535 |
| 60 | negative regulation of cholesterol transport (GO:0032375) | 3.70698969 |
| 61 | negative regulation of sterol transport (GO:0032372) | 3.70698969 |
| 62 | alpha-amino acid catabolic process (GO:1901606) | 3.69663697 |
| 63 | aromatic amino acid family metabolic process (GO:0009072) | 3.67995145 |
| 64 | cellular modified amino acid catabolic process (GO:0042219) | 3.67536181 |
| 65 | histone H3-K36 demethylation (GO:0070544) | 3.67103740 |
| 66 | nuclear pore complex assembly (GO:0051292) | 3.66351247 |
| 67 | response to muramyl dipeptide (GO:0032495) | 3.65684935 |
| 68 | oocyte development (GO:0048599) | 3.64579021 |
| 69 | protein kinase C signaling (GO:0070528) | 3.62676228 |
| 70 | detection of external biotic stimulus (GO:0098581) | 3.61139883 |
| 71 | amino-acid betaine metabolic process (GO:0006577) | 3.60095800 |
| 72 | serine family amino acid biosynthetic process (GO:0009070) | 3.59738353 |
| 73 | regulation of fibrinolysis (GO:0051917) | 3.59514179 |
| 74 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.58763239 |
| 75 | negative regulation of cell killing (GO:0031342) | 3.58763239 |
| 76 | ethanol oxidation (GO:0006069) | 3.56145821 |
| 77 | valine metabolic process (GO:0006573) | 3.54288521 |
| 78 | regulation of complement activation (GO:0030449) | 3.52247668 |
| 79 | reverse cholesterol transport (GO:0043691) | 3.51200516 |
| 80 | cellular ketone body metabolic process (GO:0046950) | 3.49625344 |
| 81 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.48019208 |
| 82 | response to host immune response (GO:0052572) | 3.48019208 |
| 83 | regulation of hypersensitivity (GO:0002883) | 3.44420448 |
| 84 | cellular amino acid catabolic process (GO:0009063) | 3.43583106 |
| 85 | regulation of mast cell degranulation (GO:0043304) | 3.43475551 |
| 86 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.41039976 |
| 87 | regulation of cholesterol metabolic process (GO:0090181) | 3.40588837 |
| 88 | regulation of triglyceride catabolic process (GO:0010896) | 3.40060415 |
| 89 | phospholipid efflux (GO:0033700) | 3.39838801 |
| 90 | response to host (GO:0075136) | 3.39210138 |
| 91 | response to host defenses (GO:0052200) | 3.39210138 |
| 92 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.39210138 |
| 93 | bile acid and bile salt transport (GO:0015721) | 3.38607983 |
| 94 | intestinal cholesterol absorption (GO:0030299) | 3.36670993 |
| 95 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.36601840 |
| 96 | regulation of leukocyte degranulation (GO:0043300) | 3.35714051 |
| 97 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.34272255 |
| 98 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.33929365 |
| 99 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.32086360 |
| 100 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.30418793 |
| 101 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.30140590 |
| 102 | tyrosine metabolic process (GO:0006570) | 3.29413134 |
| 103 | neutrophil mediated immunity (GO:0002446) | 3.28607774 |
| 104 | indolalkylamine metabolic process (GO:0006586) | 3.26790237 |
| 105 | nuclear pore organization (GO:0006999) | 3.26668155 |
| 106 | macromolecular complex remodeling (GO:0034367) | 3.25937535 |
| 107 | plasma lipoprotein particle remodeling (GO:0034369) | 3.25937535 |
| 108 | protein-lipid complex remodeling (GO:0034368) | 3.25937535 |
| 109 | drug catabolic process (GO:0042737) | 3.25579841 |
| 110 | citrulline biosynthetic process (GO:0019240) | 3.25072294 |
| 111 | acylglycerol homeostasis (GO:0055090) | 3.23946211 |
| 112 | triglyceride homeostasis (GO:0070328) | 3.23946211 |
| 113 | hypotonic response (GO:0006971) | 3.23097143 |
| 114 | histone H3-K9 demethylation (GO:0033169) | 3.21510607 |
| 115 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.20593905 |
| 116 | plasma lipoprotein particle clearance (GO:0034381) | 3.19763889 |
| 117 | B cell receptor signaling pathway (GO:0050853) | 3.17686411 |
| 118 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.17588893 |
| 119 | regulation of bile acid biosynthetic process (GO:0070857) | 3.15784061 |
| 120 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.15068190 |
| 121 | gene silencing by RNA (GO:0031047) | 3.14790114 |
| 122 | regulation of RNA export from nucleus (GO:0046831) | 3.12759166 |
| 123 | glutamate metabolic process (GO:0006536) | 3.12066175 |
| 124 | aspartate family amino acid catabolic process (GO:0009068) | 3.10603912 |
| 125 | cholesterol homeostasis (GO:0042632) | 3.10358249 |
| 126 | acetyl-CoA metabolic process (GO:0006084) | 3.10325906 |
| 127 | fatty acid oxidation (GO:0019395) | 3.10293624 |
| 128 | sterol homeostasis (GO:0055092) | 3.09904075 |
| 129 | detection of biotic stimulus (GO:0009595) | 3.09862233 |
| 130 | short-chain fatty acid metabolic process (GO:0046459) | 3.09468129 |
| 131 | fatty acid beta-oxidation (GO:0006635) | 3.09161388 |
| 132 | negative regulation of interleukin-12 production (GO:0032695) | 3.08565173 |
| 133 | coenzyme catabolic process (GO:0009109) | 3.06625352 |
| 134 | fatty acid homeostasis (GO:0055089) | 3.05631431 |
| 135 | B cell mediated immunity (GO:0019724) | 3.05418632 |
| 136 | cholesterol efflux (GO:0033344) | 3.04984812 |
| 137 | microglial cell activation (GO:0001774) | 3.04515228 |
| 138 | positive regulation of mast cell activation (GO:0033005) | 3.04230788 |
| 139 | regulation of cholesterol esterification (GO:0010872) | 3.03963594 |
| 140 | * DNA alkylation (GO:0006305) | 3.03705169 |
| 141 | * DNA methylation (GO:0006306) | 3.03705169 |
| 142 | male meiosis (GO:0007140) | 3.03408392 |
| 143 | neutrophil activation (GO:0042119) | 3.03190458 |
| 144 | macrophage activation (GO:0042116) | 3.02112967 |
| 145 | regulation of cholesterol homeostasis (GO:2000188) | 3.01951866 |
| 146 | lipid oxidation (GO:0034440) | 3.00908456 |
| 147 | growth hormone receptor signaling pathway (GO:0060396) | 3.00115414 |
| 148 | benzene-containing compound metabolic process (GO:0042537) | 2.99077860 |
| 149 | carboxylic acid catabolic process (GO:0046395) | 2.98988826 |
| 150 | organic acid catabolic process (GO:0016054) | 2.98988826 |
| 151 | one-carbon metabolic process (GO:0006730) | 2.98947462 |
| 152 | mitotic chromosome condensation (GO:0007076) | 2.97596128 |
| 153 | fibrinolysis (GO:0042730) | 2.96909210 |
| 154 | N-terminal protein amino acid acetylation (GO:0006474) | 2.96329785 |
| 155 | ketone body metabolic process (GO:1902224) | 2.95350566 |
| 156 | 2-oxoglutarate metabolic process (GO:0006103) | 2.94701704 |
| 157 | positive regulation of leukocyte degranulation (GO:0043302) | 2.94201296 |
| 158 | positive regulation of B cell differentiation (GO:0045579) | 2.93620594 |
| 159 | germinal center formation (GO:0002467) | 2.93495773 |
| 160 | imidazole-containing compound metabolic process (GO:0052803) | 2.91892164 |
| 161 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.91598387 |
| 162 | positive regulation of mast cell degranulation (GO:0043306) | 2.91009442 |
| 163 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.91009442 |
| 164 | cytolysis (GO:0019835) | 2.90470266 |
| 165 | drug transmembrane transport (GO:0006855) | 2.90090008 |
| 166 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.90007950 |
| 167 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.87874000 |
| 168 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.86292133 |
| 169 | negative regulation of histone methylation (GO:0031061) | 2.79728931 |
| 170 | histone H3-K4 trimethylation (GO:0080182) | 2.77774042 |
| 171 | dosage compensation (GO:0007549) | 2.77277519 |
| 172 | regulation of histone H3-K9 methylation (GO:0051570) | 2.76571469 |
| 173 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76229617 |
| 174 | regulation of regulated secretory pathway (GO:1903305) | 2.75894527 |
| 175 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.75202090 |
| 176 | granulocyte activation (GO:0036230) | 2.74470031 |
| 177 | myeloid cell activation involved in immune response (GO:0002275) | 2.73172208 |
| 178 | pore complex assembly (GO:0046931) | 2.70607931 |
| 179 | definitive hemopoiesis (GO:0060216) | 2.65121374 |
| 180 | leukocyte aggregation (GO:0070486) | 2.63778624 |
| 181 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.62700992 |
| 182 | regulation of cellular amide metabolic process (GO:0034248) | 2.61325847 |
| 183 | negative regulation of T cell mediated immunity (GO:0002710) | 2.60472374 |
| 184 | regulation of mast cell activation (GO:0033003) | 2.60196902 |
| 185 | multicellular organism reproduction (GO:0032504) | 2.59584224 |
| 186 | myeloid leukocyte mediated immunity (GO:0002444) | 2.56869462 |
| 187 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.56772351 |
| 188 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.56277526 |
| 189 | positive regulation of regulated secretory pathway (GO:1903307) | 2.55839485 |
| 190 | respiratory burst (GO:0045730) | 2.51451450 |
| 191 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.50342979 |
| 192 | histone H3-K4 methylation (GO:0051568) | 2.50038091 |
| 193 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.48145100 |
| 194 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.46762551 |
| 195 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.46745659 |
| 196 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.44436375 |
| 197 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.43266253 |
| 198 | * histone lysine demethylation (GO:0070076) | 2.42021030 |
| 199 | peptidyl-threonine phosphorylation (GO:0018107) | 2.39057166 |
| 200 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.38833244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.07866585 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.81614345 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.31190999 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.03936621 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.78377781 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.21034951 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.14617152 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03971631 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.01361733 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.90041529 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.78617894 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.78304723 |
| 13 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.72532563 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.70898489 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.66640230 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.64360756 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.58273685 |
| 18 | SPI1_23127762_ChIP-Seq_K562_Human | 2.55277785 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.48972583 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.41371957 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34454110 |
| 22 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.29756774 |
| 23 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.27584993 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.23784285 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.18801284 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.12644274 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.02677625 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.98008546 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96311422 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.82923873 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80365282 |
| 32 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.75163819 |
| 33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.74192200 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.72968097 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71913318 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.69700038 |
| 37 | GATA1_19941826_ChIP-Seq_K562_Human | 1.67256882 |
| 38 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.63961477 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.57894350 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54416872 |
| 41 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.54296206 |
| 42 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.52211450 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50865361 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.50592534 |
| 45 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.49030442 |
| 46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.48290640 |
| 47 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.48158072 |
| 48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.46711597 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.46119693 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44089812 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.42141606 |
| 52 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.41449772 |
| 53 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.40314798 |
| 54 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.39576940 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.36608328 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35941456 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.35381352 |
| 58 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33316291 |
| 59 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.29752130 |
| 60 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.28902348 |
| 61 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28165482 |
| 62 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.27596614 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25663778 |
| 64 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.21605299 |
| 65 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.21268838 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18598362 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17291136 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.16853247 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16397160 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14006216 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13026923 |
| 72 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12015517 |
| 73 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11162709 |
| 74 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10639502 |
| 75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10559840 |
| 76 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.09522061 |
| 77 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09179119 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06536286 |
| 79 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04648597 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04553949 |
| 81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03521278 |
| 82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03227045 |
| 83 | MYB_26560356_Chip-Seq_TH1_Human | 1.02160373 |
| 84 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.01836573 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01386511 |
| 86 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.00939696 |
| 87 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00482651 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99548775 |
| 89 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.99401449 |
| 90 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99150196 |
| 91 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99078003 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 0.98179140 |
| 93 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.98045340 |
| 94 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96623871 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96221885 |
| 96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95698776 |
| 97 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95250305 |
| 98 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.94991858 |
| 99 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.94356597 |
| 100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94044592 |
| 101 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.94017647 |
| 102 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.93834991 |
| 103 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93503007 |
| 104 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92746081 |
| 105 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92724706 |
| 106 | KDM2B_26808549_Chip-Seq_K562_Human | 0.92640483 |
| 107 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92387106 |
| 108 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92387106 |
| 109 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92286159 |
| 110 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90908678 |
| 111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90048188 |
| 112 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.89415392 |
| 113 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.89258380 |
| 114 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88976197 |
| 115 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88487840 |
| 116 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86674652 |
| 117 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86258693 |
| 118 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84834170 |
| 119 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.83590985 |
| 120 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.83525773 |
| 121 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.82059630 |
| 122 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.81864022 |
| 123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79306163 |
| 124 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.79117649 |
| 125 | MYB_26560356_Chip-Seq_TH2_Human | 0.77561136 |
| 126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.76049508 |
| 127 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75898733 |
| 128 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75264483 |
| 129 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.74242772 |
| 130 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73507853 |
| 131 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.72692727 |
| 132 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72477478 |
| 133 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.71879199 |
| 134 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.71879199 |
| 135 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.70707558 |
| 136 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.70637033 |
| 137 | GATA3_26560356_Chip-Seq_TH2_Human | 0.70169958 |
| 138 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.70166757 |
| 139 | UTX_26944678_Chip-Seq_JUKART_Human | 0.69658052 |
| 140 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68782465 |
| 141 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.68480331 |
| 142 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.68416921 |
| 143 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.68416351 |
| 144 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.67671121 |
| 145 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.66736550 |
| 146 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.65612522 |
| 147 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.65602042 |
| 148 | ATF3_27146783_Chip-Seq_COLON_Human | 0.65263628 |
| 149 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.64309444 |
| 150 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.64006132 |
| 151 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.62974963 |
| 152 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61706339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.91083019 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.83310338 |
| 3 | MP0005365_abnormal_bile_salt | 4.71120167 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.19630370 |
| 5 | MP0003303_peritoneal_inflammation | 3.15515197 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.07432466 |
| 7 | MP0003436_decreased_susceptibility_to | 3.00944297 |
| 8 | MP0003252_abnormal_bile_duct | 2.95808660 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.82703203 |
| 10 | MP0004510_myositis | 2.74254140 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.72633678 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.52225923 |
| 13 | MP0003724_increased_susceptibility_to | 2.48303397 |
| 14 | MP0008260_abnormal_autophagy | 2.44374573 |
| 15 | MP0008057_abnormal_DNA_replication | 2.39032554 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.38970449 |
| 17 | MP0002419_abnormal_innate_immunity | 2.32835264 |
| 18 | MP0002396_abnormal_hematopoietic_system | 2.29311446 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.28532175 |
| 20 | MP0009697_abnormal_copulation | 2.24954315 |
| 21 | MP0009840_abnormal_foam_cell | 2.20396837 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 2.17685677 |
| 23 | MP0002254_reproductive_system_inflammat | 2.16912770 |
| 24 | MP0010329_abnormal_lipoprotein_level | 2.13615960 |
| 25 | MP0003183_abnormal_peptide_metabolism | 2.07512964 |
| 26 | MP0003172_abnormal_lysosome_physiology | 2.05933466 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.03625159 |
| 28 | MP0005076_abnormal_cell_differentiation | 2.03077467 |
| 29 | MP0005083_abnormal_biliary_tract | 1.98804121 |
| 30 | MP0005451_abnormal_body_composition | 1.92597926 |
| 31 | MP0005025_abnormal_response_to | 1.90528142 |
| 32 | MP0005408_hypopigmentation | 1.88466876 |
| 33 | MP0005332_abnormal_amino_acid | 1.87943768 |
| 34 | MP0003828_pulmonary_edema | 1.87506656 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.84627506 |
| 36 | MP0005409_darkened_coat_color | 1.80047582 |
| 37 | MP0000609_abnormal_liver_physiology | 1.79149608 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.78905676 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.78065025 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.73713155 |
| 41 | MP0001819_abnormal_immune_cell | 1.70583083 |
| 42 | MP0002723_abnormal_immune_serum | 1.69219773 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.68884107 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.68884107 |
| 45 | MP0002132_abnormal_respiratory_system | 1.66734666 |
| 46 | MP0003868_abnormal_feces_composition | 1.64707568 |
| 47 | MP0002398_abnormal_bone_marrow | 1.62639069 |
| 48 | MP0001790_abnormal_immune_system | 1.55847837 |
| 49 | MP0005387_immune_system_phenotype | 1.55847837 |
| 50 | MP0009278_abnormal_bone_marrow | 1.50527422 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.49198759 |
| 52 | MP0002405_respiratory_system_inflammati | 1.40662522 |
| 53 | MP0010307_abnormal_tumor_latency | 1.40589484 |
| 54 | MP0002006_tumorigenesis | 1.39895825 |
| 55 | MP0009785_altered_susceptibility_to | 1.39381660 |
| 56 | MP0000858_altered_metastatic_potential | 1.39026599 |
| 57 | MP0003091_abnormal_cell_migration | 1.37153308 |
| 58 | MP0000716_abnormal_immune_system | 1.36203703 |
| 59 | MP0006082_CNS_inflammation | 1.34661123 |
| 60 | MP0002722_abnormal_immune_system | 1.30177499 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 1.29076517 |
| 62 | MP0001873_stomach_inflammation | 1.27266842 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.25912722 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.23457815 |
| 65 | MP0003890_abnormal_embryonic-extraembry | 1.20459629 |
| 66 | MP0000685_abnormal_immune_system | 1.20297615 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.18515377 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.17525601 |
| 69 | MP0009643_abnormal_urine_homeostasis | 1.16709252 |
| 70 | MP0003195_calcinosis | 1.16026007 |
| 71 | MP0002429_abnormal_blood_cell | 1.15652084 |
| 72 | MP0000015_abnormal_ear_pigmentation | 1.14412169 |
| 73 | MP0000427_abnormal_hair_cycle | 1.13845307 |
| 74 | MP0005621_abnormal_cell_physiology | 1.13819670 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 1.13608191 |
| 76 | MP0004019_abnormal_vitamin_homeostasis | 1.11916268 |
| 77 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11131818 |
| 78 | MP0001533_abnormal_skeleton_physiology | 1.10580111 |
| 79 | MP0006292_abnormal_olfactory_placode | 1.09720084 |
| 80 | MP0005220_abnormal_exocrine_pancreas | 1.08728867 |
| 81 | MP0002148_abnormal_hypersensitivity_rea | 1.08338317 |
| 82 | MP0004233_abnormal_muscle_weight | 1.07558881 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 1.07265530 |
| 84 | MP0000598_abnormal_liver_morphology | 1.05935589 |
| 85 | MP0001851_eye_inflammation | 1.04744719 |
| 86 | MP0001346_abnormal_lacrimal_gland | 1.02833132 |
| 87 | MP0004264_abnormal_extraembryonic_tissu | 1.02332646 |
| 88 | MP0001835_abnormal_antigen_presentation | 1.02267354 |
| 89 | MP0010678_abnormal_skin_adnexa | 1.01030602 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 1.00998742 |
| 91 | MP0004883_abnormal_blood_vessel | 0.99585319 |
| 92 | MP0002009_preneoplasia | 0.98724411 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 0.98390417 |
| 94 | MP0005647_abnormal_sex_gland | 0.98112169 |
| 95 | MP0003123_paternal_imprinting | 0.93441764 |
| 96 | MP0005671_abnormal_response_to | 0.93054685 |
| 97 | MP0005164_abnormal_response_to | 0.92912323 |
| 98 | MP0001764_abnormal_homeostasis | 0.91295525 |
| 99 | MP0004947_skin_inflammation | 0.88849486 |
| 100 | * MP0003718_maternal_effect | 0.87437186 |
| 101 | * MP0003699_abnormal_female_reproductive | 0.86246726 |
| 102 | MP0001853_heart_inflammation | 0.85444543 |
| 103 | MP0005384_cellular_phenotype | 0.84865022 |
| 104 | MP0003011_delayed_dark_adaptation | 0.84529755 |
| 105 | MP0003075_altered_response_to | 0.83923064 |
| 106 | MP0001915_intracranial_hemorrhage | 0.83417874 |
| 107 | MP0003690_abnormal_glial_cell | 0.83167892 |
| 108 | MP0003763_abnormal_thymus_physiology | 0.81771883 |
| 109 | MP0009763_increased_sensitivity_to | 0.81346280 |
| 110 | MP0000350_abnormal_cell_proliferation | 0.80926690 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.80657604 |
| 112 | MP0003077_abnormal_cell_cycle | 0.80224040 |
| 113 | MP0009333_abnormal_splenocyte_physiolog | 0.78694704 |
| 114 | MP0000377_abnormal_hair_follicle | 0.78542281 |
| 115 | MP0001919_abnormal_reproductive_system | 0.77863238 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77828574 |
| 117 | MP0009115_abnormal_fat_cell | 0.77500708 |
| 118 | MP0000579_abnormal_nail_morphology | 0.77400663 |
| 119 | MP0001800_abnormal_humoral_immune | 0.77184183 |
| 120 | MP0002019_abnormal_tumor_incidence | 0.76460729 |
| 121 | MP0000653_abnormal_sex_gland | 0.76367775 |
| 122 | MP0001243_abnormal_dermal_layer | 0.75661023 |
| 123 | MP0001119_abnormal_female_reproductive | 0.75564654 |
| 124 | MP0005501_abnormal_skin_physiology | 0.75218893 |
| 125 | MP0003448_altered_tumor_morphology | 0.75012989 |
| 126 | MP0001929_abnormal_gametogenesis | 0.74863356 |
| 127 | MP0003866_abnormal_defecation | 0.73697444 |
| 128 | MP0002998_abnormal_bone_remodeling | 0.73500884 |
| 129 | MP0002210_abnormal_sex_determination | 0.72185463 |
| 130 | MP0000678_abnormal_parathyroid_gland | 0.71960490 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.71921538 |
| 132 | MP0005166_decreased_susceptibility_to | 0.71866144 |
| 133 | MP0001661_extended_life_span | 0.71002149 |
| 134 | MP0010094_abnormal_chromosome_stability | 0.70828236 |
| 135 | MP0001216_abnormal_epidermal_layer | 0.70486139 |
| 136 | MP0003329_amyloid_beta_deposits | 0.70179571 |
| 137 | MP0009384_cardiac_valve_regurgitation | 0.69484789 |
| 138 | MP0000465_gastrointestinal_hemorrhage | 0.68472081 |
| 139 | MP0002877_abnormal_melanocyte_morpholog | 0.68314545 |
| 140 | MP0009764_decreased_sensitivity_to | 0.67458380 |
| 141 | MP0004381_abnormal_hair_follicle | 0.65447758 |
| 142 | MP0000604_amyloidosis | 0.64844155 |
| 143 | MP0010155_abnormal_intestine_physiology | 0.63462862 |
| 144 | MP0001730_embryonic_growth_arrest | 0.63302700 |
| 145 | MP0000383_abnormal_hair_follicle | 0.62891912 |
| 146 | MP0002796_impaired_skin_barrier | 0.61397458 |
| 147 | MP0005310_abnormal_salivary_gland | 0.61335421 |
| 148 | MP0001145_abnormal_male_reproductive | 0.59765311 |
| 149 | MP0002136_abnormal_kidney_physiology | 0.59551269 |
| 150 | MP0002098_abnormal_vibrissa_morphology | 0.58768270 |
| 151 | * MP0005395_other_phenotype | 0.58733034 |
| 152 | MP0008469_abnormal_protein_level | 0.58431221 |
| 153 | MP0005666_abnormal_adipose_tissue | 0.55076694 |
| 154 | MP0005187_abnormal_penis_morphology | 0.54551552 |
| 155 | MP0005058_abnormal_lysosome_morphology | 0.54265943 |
| 156 | MP0002060_abnormal_skin_morphology | 0.54135309 |
| 157 | MP0002928_abnormal_bile_duct | 0.53850140 |
| 158 | MP0001845_abnormal_inflammatory_respons | 0.52808009 |
| 159 | MP0004808_abnormal_hematopoietic_stem | 0.52794106 |
| 160 | MP0002971_abnormal_brown_adipose | 0.52642177 |
| 161 | MP0005464_abnormal_platelet_physiology | 0.52638799 |
| 162 | MP0005023_abnormal_wound_healing | 0.50847089 |
| 163 | MP0001756_abnormal_urination | 0.50722252 |
| 164 | MP0000767_abnormal_smooth_muscle | 0.50504711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.18782578 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.09356041 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.58006357 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.42667702 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 4.99445911 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.81325577 |
| 7 | Xanthomatosis (HP:0000991) | 4.59835700 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.54484228 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.46673896 |
| 10 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.06956511 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.06195588 |
| 12 | Fat malabsorption (HP:0002630) | 3.88528717 |
| 13 | Hyperammonemia (HP:0001987) | 3.84261984 |
| 14 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.84051354 |
| 15 | Complement deficiency (HP:0004431) | 3.78782910 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 3.77813105 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.68586696 |
| 18 | Prolonged partial thromboplastin time (HP:0003645) | 3.64598217 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.54724274 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.51466580 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.46029285 |
| 22 | Epidermoid cyst (HP:0200040) | 3.43277152 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 3.40425334 |
| 24 | Ketosis (HP:0001946) | 3.40318206 |
| 25 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.39211360 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.39151796 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.33107840 |
| 28 | Cortical dysplasia (HP:0002539) | 3.23954992 |
| 29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.22506769 |
| 30 | Abnormality of the fingertips (HP:0001211) | 3.18040669 |
| 31 | Hyperglycinuria (HP:0003108) | 3.16931457 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.15545125 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.14224136 |
| 34 | Hyperglycinemia (HP:0002154) | 3.12574767 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 3.11537639 |
| 36 | Steatorrhea (HP:0002570) | 3.10426089 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 3.09003252 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.09003252 |
| 39 | Gingivitis (HP:0000230) | 3.08672339 |
| 40 | Joint hemorrhage (HP:0005261) | 3.00875735 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 3.00433660 |
| 42 | Myositis (HP:0100614) | 2.99640547 |
| 43 | Myocardial infarction (HP:0001658) | 2.96500887 |
| 44 | Spastic diplegia (HP:0001264) | 2.91598950 |
| 45 | Abnormality of the intrinsic pathway (HP:0010989) | 2.87219632 |
| 46 | Subacute progressive viral hepatitis (HP:0006572) | 2.80493731 |
| 47 | Recurrent skin infections (HP:0001581) | 2.79993272 |
| 48 | Abnormality of nucleobase metabolism (HP:0010932) | 2.79695387 |
| 49 | Malnutrition (HP:0004395) | 2.75665601 |
| 50 | Recurrent fungal infections (HP:0002841) | 2.71334707 |
| 51 | Obstructive lung disease (HP:0006536) | 2.71069068 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.71069068 |
| 53 | Hypochromic microcytic anemia (HP:0004840) | 2.65577892 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.63827671 |
| 55 | Orchitis (HP:0100796) | 2.63382701 |
| 56 | Viral hepatitis (HP:0006562) | 2.63096758 |
| 57 | Esophageal varix (HP:0002040) | 2.62462918 |
| 58 | Abnormality of purine metabolism (HP:0004352) | 2.62431012 |
| 59 | Conjugated hyperbilirubinemia (HP:0002908) | 2.59898635 |
| 60 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.55476365 |
| 61 | Urticaria (HP:0001025) | 2.54742791 |
| 62 | Cellulitis (HP:0100658) | 2.53215612 |
| 63 | Optic neuritis (HP:0100653) | 2.53067893 |
| 64 | Retrobulbar optic neuritis (HP:0100654) | 2.53067893 |
| 65 | Osteomyelitis (HP:0002754) | 2.52549254 |
| 66 | Hypercholesterolemia (HP:0003124) | 2.51380865 |
| 67 | Gingival bleeding (HP:0000225) | 2.51321783 |
| 68 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.51244146 |
| 69 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.51244146 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.51065097 |
| 71 | Increased IgE level (HP:0003212) | 2.48369642 |
| 72 | Loss of speech (HP:0002371) | 2.47083572 |
| 73 | Gout (HP:0001997) | 2.43414702 |
| 74 | Limb-girdle muscle atrophy (HP:0003797) | 2.43238144 |
| 75 | Acute myeloid leukemia (HP:0004808) | 2.43224094 |
| 76 | Mediastinal lymphadenopathy (HP:0100721) | 2.42797205 |
| 77 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.42358470 |
| 78 | Abnormality of complement system (HP:0005339) | 2.39990165 |
| 79 | Lip pit (HP:0100267) | 2.37680870 |
| 80 | Recurrent viral infections (HP:0004429) | 2.36135485 |
| 81 | Polycythemia (HP:0001901) | 2.36065962 |
| 82 | Fatigue (HP:0012378) | 2.35725855 |
| 83 | Flat acetabular roof (HP:0003180) | 2.35650593 |
| 84 | Hemorrhage of the eye (HP:0011885) | 2.34465267 |
| 85 | Prolonged bleeding time (HP:0003010) | 2.32264663 |
| 86 | Abnormality of serum amino acid levels (HP:0003112) | 2.31482585 |
| 87 | Gastrointestinal inflammation (HP:0004386) | 2.31074073 |
| 88 | Meningitis (HP:0001287) | 2.30952476 |
| 89 | Spontaneous abortion (HP:0005268) | 2.28233641 |
| 90 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.26899187 |
| 91 | Recurrent cutaneous fungal infections (HP:0011370) | 2.26899187 |
| 92 | Cholecystitis (HP:0001082) | 2.24319586 |
| 93 | Abnormal gallbladder physiology (HP:0012438) | 2.24319586 |
| 94 | Inflammation of the large intestine (HP:0002037) | 2.23898014 |
| 95 | Dysmetric saccades (HP:0000641) | 2.23571727 |
| 96 | Fair hair (HP:0002286) | 2.23229800 |
| 97 | Hyperbilirubinemia (HP:0002904) | 2.22524948 |
| 98 | Ketoacidosis (HP:0001993) | 2.20302171 |
| 99 | Thyroid carcinoma (HP:0002890) | 2.16917045 |
| 100 | Chest pain (HP:0100749) | 2.13214645 |
| 101 | Azoospermia (HP:0000027) | 2.12205587 |
| 102 | Periodontitis (HP:0000704) | 2.12169807 |
| 103 | Arterial thrombosis (HP:0004420) | 2.11432203 |
| 104 | Delayed CNS myelination (HP:0002188) | 2.10194847 |
| 105 | Truncal obesity (HP:0001956) | 2.09900632 |
| 106 | Ankyloglossia (HP:0010296) | 2.08630297 |
| 107 | Vasculitis (HP:0002633) | 2.08179724 |
| 108 | Amyloidosis (HP:0011034) | 2.05736596 |
| 109 | Skin nodule (HP:0200036) | 2.05018615 |
| 110 | Increased mean platelet volume (HP:0011877) | 2.04804821 |
| 111 | Keratoconjunctivitis sicca (HP:0001097) | 2.03913935 |
| 112 | Apathy (HP:0000741) | 2.02805964 |
| 113 | Cheilitis (HP:0100825) | 2.02669465 |
| 114 | Brushfield spots (HP:0001088) | 2.02012218 |
| 115 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.01096163 |
| 116 | Diminished motivation (HP:0000745) | 2.01015116 |
| 117 | Abnormal gallbladder morphology (HP:0012437) | 1.98488456 |
| 118 | Hyperglycemia (HP:0003074) | 1.97658666 |
| 119 | Slow saccadic eye movements (HP:0000514) | 1.97624790 |
| 120 | Combined immunodeficiency (HP:0005387) | 1.97426658 |
| 121 | Epistaxis (HP:0000421) | 1.96809781 |
| 122 | Acanthocytosis (HP:0001927) | 1.96371749 |
| 123 | Nasal polyposis (HP:0100582) | 1.96250583 |
| 124 | Male infertility (HP:0003251) | 1.95535378 |
| 125 | Cholelithiasis (HP:0001081) | 1.95055872 |
| 126 | Pigmentary retinal degeneration (HP:0001146) | 1.92415159 |
| 127 | Lower limb hyperreflexia (HP:0002395) | 1.92173252 |
| 128 | Episodic fever (HP:0001954) | 1.90955512 |
| 129 | Obstructive sleep apnea (HP:0002870) | 1.90143122 |
| 130 | Stomatitis (HP:0010280) | 1.89307792 |
| 131 | Abnormal platelet volume (HP:0011876) | 1.85352624 |
| 132 | Heterotopia (HP:0002282) | 1.85251305 |
| 133 | Increased purine levels (HP:0004368) | 1.84946766 |
| 134 | Hyperuricemia (HP:0002149) | 1.84946766 |
| 135 | Metabolic acidosis (HP:0001942) | 1.84778948 |
| 136 | Abnormality of the peritoneum (HP:0002585) | 1.81402560 |
| 137 | Pancreatitis (HP:0001733) | 1.80868405 |
| 138 | Mitral stenosis (HP:0001718) | 1.80032970 |
| 139 | Abnormality of proline metabolism (HP:0010907) | 1.79469635 |
| 140 | Hydroxyprolinuria (HP:0003080) | 1.79469635 |
| 141 | Hypoglycemic seizures (HP:0002173) | 1.79342028 |
| 142 | Thrombophlebitis (HP:0004418) | 1.78524487 |
| 143 | Absent/shortened dynein arms (HP:0200106) | 1.78421394 |
| 144 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.78421394 |
| 145 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.75400221 |
| 146 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75338520 |
| 147 | Dicarboxylic aciduria (HP:0003215) | 1.75338520 |
| 148 | Deep philtrum (HP:0002002) | 1.74495348 |
| 149 | Skin ulcer (HP:0200042) | 1.73464144 |
| 150 | Chorioretinal atrophy (HP:0000533) | 1.73287257 |
| 151 | Sensorimotor neuropathy (HP:0007141) | 1.72827691 |
| 152 | Menorrhagia (HP:0000132) | 1.72073670 |
| 153 | Late onset (HP:0003584) | 1.71757601 |
| 154 | Increased connective tissue (HP:0009025) | 1.69974760 |
| 155 | Infertility (HP:0000789) | 1.69667056 |
| 156 | Subaortic stenosis (HP:0001682) | 1.69245005 |
| 157 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.69245005 |
| 158 | Back pain (HP:0003418) | 1.67728477 |
| 159 | Hemoptysis (HP:0002105) | 1.67436109 |
| 160 | Encephalitis (HP:0002383) | 1.66741197 |
| 161 | Papillary thyroid carcinoma (HP:0002895) | 1.66006901 |
| 162 | Bowel incontinence (HP:0002607) | 1.65768086 |
| 163 | Abnormality of the endocardium (HP:0004306) | 1.65759864 |
| 164 | Micronodular cirrhosis (HP:0001413) | 1.65684361 |
| 165 | Abnormal ciliary motility (HP:0012262) | 1.65105524 |
| 166 | Peritonitis (HP:0002586) | 1.64833540 |
| 167 | Hepatitis (HP:0012115) | 1.63939979 |
| 168 | Difficulty running (HP:0009046) | 1.62994043 |
| 169 | Keratoconjunctivitis (HP:0001096) | 1.62682559 |
| 170 | Neuronal loss in central nervous system (HP:0002529) | 1.62058370 |
| 171 | Abnormality of the gallbladder (HP:0005264) | 1.61847183 |
| 172 | Pseudobulbar signs (HP:0002200) | 1.61372236 |
| 173 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.61016707 |
| 174 | Upper motor neuron abnormality (HP:0002127) | 1.60786128 |
| 175 | Gastrointestinal stroma tumor (HP:0100723) | 1.60246197 |
| 176 | Generalized aminoaciduria (HP:0002909) | 1.59274298 |
| 177 | Colitis (HP:0002583) | 1.57976765 |
| 178 | Coarse hair (HP:0002208) | 1.57883221 |
| 179 | Abnormal spermatogenesis (HP:0008669) | 1.57690184 |
| 180 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.57436878 |
| 181 | Sepsis (HP:0100806) | 1.57068186 |
| 182 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.56486161 |
| 183 | Abnormal large intestine physiology (HP:0012700) | 1.55929544 |
| 184 | Hypoplasia of the thymus (HP:0000778) | 1.55768710 |
| 185 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.55547380 |
| 186 | Cone-rod dystrophy (HP:0000548) | 1.55264088 |
| 187 | Abnormality of the nasal mucosa (HP:0000433) | 1.54789463 |
| 188 | Termporal pattern (HP:0011008) | 1.54413296 |
| 189 | Insidious onset (HP:0003587) | 1.54413296 |
| 190 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.52755736 |
| 191 | Spastic paraparesis (HP:0002313) | 1.52508791 |
| 192 | Acute hepatic failure (HP:0006554) | 1.50873104 |
| 193 | Irritability (HP:0000737) | 1.50584997 |
| 194 | Sandal gap (HP:0001852) | 1.50213821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.10922824 |
| 2 | CDK12 | 3.57676707 |
| 3 | BCKDK | 3.31861383 |
| 4 | TAOK3 | 2.81848864 |
| 5 | PRPF4B | 2.79553254 |
| 6 | KSR2 | 2.72606230 |
| 7 | ACVR1B | 2.67442606 |
| 8 | FGFR4 | 2.53585953 |
| 9 | LATS1 | 2.52913214 |
| 10 | EEF2K | 2.51178846 |
| 11 | EPHB1 | 2.48008974 |
| 12 | MAP2K3 | 2.42418872 |
| 13 | ERN1 | 2.36726988 |
| 14 | MAP3K10 | 2.16138819 |
| 15 | SIK1 | 2.12468924 |
| 16 | PKN2 | 2.11376854 |
| 17 | BLK | 2.08513742 |
| 18 | CDK9 | 1.96694726 |
| 19 | IRAK4 | 1.95559946 |
| 20 | TYK2 | 1.83337048 |
| 21 | BRSK2 | 1.75812585 |
| 22 | BMPR2 | 1.72171628 |
| 23 | STK10 | 1.69876463 |
| 24 | TTK | 1.66622435 |
| 25 | MAP3K2 | 1.62377803 |
| 26 | ZAP70 | 1.60331902 |
| 27 | ARAF | 1.53534575 |
| 28 | BRD4 | 1.51958849 |
| 29 | TRIB3 | 1.48790607 |
| 30 | MELK | 1.47160237 |
| 31 | MAP3K13 | 1.45928770 |
| 32 | MAP3K9 | 1.45294510 |
| 33 | RAF1 | 1.42340995 |
| 34 | FGFR3 | 1.40327129 |
| 35 | MAP3K8 | 1.38178102 |
| 36 | PRKAA2 | 1.34892018 |
| 37 | KSR1 | 1.34205339 |
| 38 | IRAK3 | 1.33468305 |
| 39 | ERBB4 | 1.32933671 |
| 40 | EPHA3 | 1.32786272 |
| 41 | MAP3K1 | 1.32223876 |
| 42 | FRK | 1.30583428 |
| 43 | NEK6 | 1.30421832 |
| 44 | PTK6 | 1.26355276 |
| 45 | WNK1 | 1.23736886 |
| 46 | MAP4K1 | 1.21445171 |
| 47 | STK3 | 1.20894763 |
| 48 | TAOK1 | 1.19899447 |
| 49 | CDK4 | 1.18979585 |
| 50 | FES | 1.17545133 |
| 51 | CHUK | 1.16475676 |
| 52 | FLT3 | 1.15486476 |
| 53 | YES1 | 1.15469110 |
| 54 | MAP3K6 | 1.15316235 |
| 55 | NEK9 | 1.13944131 |
| 56 | MAP3K3 | 1.12624400 |
| 57 | JAK1 | 1.12335624 |
| 58 | PRKAA1 | 1.10990163 |
| 59 | MAP3K14 | 1.10547772 |
| 60 | FGFR2 | 1.06929195 |
| 61 | MAPK11 | 1.06724522 |
| 62 | MARK2 | 1.04097007 |
| 63 | MOS | 1.04087878 |
| 64 | MATK | 1.03818477 |
| 65 | HCK | 1.01519248 |
| 66 | CAMK1D | 1.01099117 |
| 67 | LRRK2 | 0.99902802 |
| 68 | TRPM7 | 0.99039963 |
| 69 | MTOR | 0.97675174 |
| 70 | CSF1R | 0.97659539 |
| 71 | SYK | 0.94769322 |
| 72 | STK11 | 0.94699573 |
| 73 | RPS6KA4 | 0.94521605 |
| 74 | RPS6KB2 | 0.93063007 |
| 75 | CDK7 | 0.91264728 |
| 76 | CDC7 | 0.90733749 |
| 77 | IRAK2 | 0.90715918 |
| 78 | RIPK1 | 0.88953035 |
| 79 | TTN | 0.88646561 |
| 80 | CDK6 | 0.87510519 |
| 81 | JAK3 | 0.87385823 |
| 82 | CSNK1G1 | 0.86280130 |
| 83 | CSNK1A1L | 0.85909814 |
| 84 | FGR | 0.84640952 |
| 85 | CAMK1G | 0.84287154 |
| 86 | STK24 | 0.83863169 |
| 87 | JAK2 | 0.83193130 |
| 88 | NUAK1 | 0.81879351 |
| 89 | PLK4 | 0.80161544 |
| 90 | BRAF | 0.79161105 |
| 91 | IKBKB | 0.78959771 |
| 92 | RET | 0.78746050 |
| 93 | MAP3K7 | 0.78015500 |
| 94 | MST4 | 0.77897438 |
| 95 | TNK2 | 0.75684319 |
| 96 | IRAK1 | 0.75682642 |
| 97 | SMG1 | 0.75533888 |
| 98 | STK4 | 0.74815967 |
| 99 | NLK | 0.73994611 |
| 100 | CDC42BPA | 0.72002368 |
| 101 | TAOK2 | 0.71779940 |
| 102 | MAPKAPK3 | 0.71754308 |
| 103 | NEK2 | 0.71527950 |
| 104 | DYRK1B | 0.71464710 |
| 105 | TBK1 | 0.70546671 |
| 106 | MARK3 | 0.66765013 |
| 107 | ICK | 0.66751118 |
| 108 | PIK3CG | 0.66472388 |
| 109 | IKBKE | 0.65551922 |
| 110 | CSK | 0.64727979 |
| 111 | STK38L | 0.62669443 |
| 112 | TEC | 0.62603683 |
| 113 | MAP3K5 | 0.61872029 |
| 114 | SGK3 | 0.61321917 |
| 115 | LYN | 0.61066591 |
| 116 | MUSK | 0.59255679 |
| 117 | SCYL2 | 0.58884111 |
| 118 | PIM1 | 0.58479781 |
| 119 | SIK3 | 0.56769058 |
| 120 | ITK | 0.56545834 |
| 121 | BTK | 0.54578952 |
| 122 | RPS6KB1 | 0.53102661 |
| 123 | CSNK1G3 | 0.53034800 |
| 124 | GRK6 | 0.52277799 |
| 125 | PDPK1 | 0.48998180 |
| 126 | CHEK2 | 0.48914408 |
| 127 | LCK | 0.48643963 |
| 128 | ATR | 0.47812265 |
| 129 | PDK1 | 0.47789305 |
| 130 | MST1R | 0.47207476 |
| 131 | CSNK1D | 0.46010254 |
| 132 | MAPK12 | 0.45432878 |
| 133 | EIF2AK1 | 0.44830575 |
| 134 | CLK1 | 0.44488825 |
| 135 | AURKB | 0.41860513 |
| 136 | CSNK1G2 | 0.41718828 |
| 137 | CAMKK2 | 0.39991925 |
| 138 | GSK3A | 0.38434032 |
| 139 | PRKD2 | 0.38088998 |
| 140 | CHEK1 | 0.37261998 |
| 141 | ATM | 0.36985549 |
| 142 | RPS6KA1 | 0.36255810 |
| 143 | BRSK1 | 0.35394857 |
| 144 | PKN1 | 0.35121962 |
| 145 | INSRR | 0.34637136 |
| 146 | MAPK10 | 0.33884630 |
| 147 | MET | 0.33276119 |
| 148 | TYRO3 | 0.32987381 |
| 149 | GRK1 | 0.32930190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.30752547 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.91678693 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29188411 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.24302916 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79629915 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.62785905 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.56203116 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50915119 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43884951 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.41167980 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.31912731 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.30128679 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25830821 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.24169275 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.19919357 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.16400076 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.04778153 |
| 18 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.99800203 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.92760803 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.91823311 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.89800513 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.89241121 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.88437515 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.85122041 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81166216 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72173383 |
| 27 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.69012118 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.68934932 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67571678 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.65289144 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.62862023 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.62487820 |
| 33 | Lysine degradation_Homo sapiens_hsa00310 | 1.61260136 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.52960864 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.52802037 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.52170254 |
| 37 | Thyroid cancer_Homo sapiens_hsa05216 | 1.50341048 |
| 38 | Endometrial cancer_Homo sapiens_hsa05213 | 1.43648067 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.41165145 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.37469521 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.37165868 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.37116973 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.36975568 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.36625853 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.35845823 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.35785541 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35414007 |
| 48 | Measles_Homo sapiens_hsa05162 | 1.35041686 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.34423197 |
| 50 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.31451709 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31028610 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.30806372 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.30030208 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28950532 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27942483 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.27293790 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27094721 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26579158 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.23871750 |
| 60 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23833125 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 1.22180971 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.22017766 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21152634 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20371677 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 1.18967328 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14159865 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.13954506 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 1.12361960 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12147054 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.10561983 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09027018 |
| 72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08567090 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.08369079 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07093516 |
| 75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05191981 |
| 76 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05109931 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 1.04527218 |
| 78 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04044868 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01861322 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.99174886 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.99069656 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.98756067 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.98165666 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.97532030 |
| 85 | Apoptosis_Homo sapiens_hsa04210 | 0.96667348 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.96157658 |
| 87 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95081401 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.94972472 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94553642 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.94508470 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.94186510 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92497679 |
| 93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.92012079 |
| 94 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91153157 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.90752523 |
| 96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90713183 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.90635467 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.90621033 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89530831 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88539483 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.86753206 |
| 102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84039365 |
| 103 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83535928 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82544780 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81503767 |
| 106 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.81249831 |
| 107 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79201576 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78470531 |
| 109 | Long-term potentiation_Homo sapiens_hsa04720 | 0.76546868 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76272545 |
| 111 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76254827 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.75644321 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75603602 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74750308 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74083342 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74072867 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72856707 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72489634 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.71466407 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.71357575 |
| 121 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70860773 |
| 122 | Adherens junction_Homo sapiens_hsa04520 | 0.70398890 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.69387708 |
| 124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64340521 |
| 125 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64297971 |
| 126 | Allograft rejection_Homo sapiens_hsa05330 | 0.64174790 |
| 127 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63999581 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.62468649 |
| 129 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61632136 |
| 130 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61324599 |
| 131 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60789652 |
| 132 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60059081 |
| 133 | Gap junction_Homo sapiens_hsa04540 | 0.59842647 |
| 134 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59473879 |
| 135 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59294456 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58528633 |
| 137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57880594 |
| 138 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56697518 |
| 139 | Pertussis_Homo sapiens_hsa05133 | 0.56536278 |
| 140 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52484965 |
| 141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51553499 |
| 142 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50094393 |
| 143 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47454397 |
| 144 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46851051 |
| 145 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45673470 |
| 146 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44856386 |
| 147 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43679978 |
| 148 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43433162 |
| 149 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.42540366 |
| 150 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40835454 |
| 151 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40727552 |
| 152 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38625300 |
| 153 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38532343 |
| 154 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33902971 |
| 155 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33533106 |
| 156 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31045754 |
| 157 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30538064 |
| 158 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.30528357 |
| 159 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.29409691 |
| 160 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29121621 |
| 161 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.27730227 |
| 162 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27659269 |
| 163 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24680295 |
| 164 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24047869 |
| 165 | Cell cycle_Homo sapiens_hsa04110 | 0.22388890 |
| 166 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21942766 |
| 167 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.21914058 |
| 168 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20835369 |
| 169 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.19444726 |
| 170 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.18438592 |
| 171 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.18110826 |
| 172 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.17936467 |
| 173 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17755876 |
| 174 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.17541133 |
| 175 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.17457625 |
| 176 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.16791648 |
| 177 | Metabolic pathways_Homo sapiens_hsa01100 | 0.16351909 |
| 178 | RNA degradation_Homo sapiens_hsa03018 | 0.16142434 |
| 179 | Hepatitis C_Homo sapiens_hsa05160 | 0.14767676 |

